Cutting Edge Technology

Our goal is to constantly evaluate the best methods of practice through evidence based research.

SpineCare Institute Research

The SpineCare Institute has paved the way in advanced surgical techniques. We have ongoing clinical studies and trials that are federally funded. Our goal is to constantly evaluate the best methods of practice through evidence based research.

Our treatments involve cutting edge technology and innovative approaches. We are pioneers in research on issues related to healing and surgical outcomes as well as leaders in minimally invasive surgery. We value the trust built within our patient community and for that reason treat many patients from overseas, who have not been able to achieve the same level of quality care internationally. Currently, we are spearheading a metabolic bone study in which we analyze bone parameters that can impact long term healing and look at individual markers on the skin that indicate how your bones heal. We use this information along with advanced technology in our ultrasounds and equipment to help propel us to the forefront of using new techniques that enhance healing. It is unique initiatives such as these, and more, that have enabled us to achieve a less than 1% infection rate after surgery, something that is very rare.

Frank P. Cammisa Jr., MD

Dr. Cammisa has authored more than 140 peer-reviewed scientific articles in prestigious medical journals such as The New England Journal of Medicine and The Journal of American Medical Association (JAMA) and greater than 35 book chapters.

He has been the recipient of numerous research grants and awards, including a $21 million dollar grant funded by the National Institutes of Health for a multi-center national study investigating surgical versus non-surgical approaches for the treatment of spinal stenosis, herniated disc, and degenerative spondylolisthesis.

His areas of research specialization span from pre-clinical studies of demineralized bone matrix and novel grafting materials to clinical investigations on artificial disc replacement for motion preservation and minimally invasive surgery. Through his research engagement, Dr. Cammisa has pioneered new surgical techniques and advanced the diagnosis and treatment of complex spinal conditions.

Dr. Cammisa Bio
Dr. Cammisa

Andrew A. Sama, MD

Dr. Sama’s research interests include disc biology, spine fusion biomechanics, patient expectations and outcomes, and fusion alternatives. He is the lead investigator at the Hospital for Special Surgery for an ongoing artificial disc replacement multi-center national clinical trial. He is the recipient of a numerous research grants, including one from the National Institutes of Health for a research trial on low back pain treatment. The patient-centered research Dr. Sama engages in has been published in peer-reviewed journals. He is also an author of a number of medical book chapters.

Dr. Sama Bio
Dr. Sama

Alexander P. Hughes, MD

Dr. Hughes is actively engaged in research involving areas of minimally invasive surgery, clinical outcomes of different surgical procedures, imaging modalities of the spine, disc biology, and connective tissue disease. He believes proper patient assessment and delivery of effective surgical treatments are important factors in optimizing spine patient outcomes. His collaboration with multidisciplinary research teams and translational investigations are vital in the development of novel methods to diagnose spinal conditions and provide innovative care to patients. He is the recipient of best research awards in international societies and peer-reviewed journals.

Dr. Hughes Bio
Dr. Hughes

Jennifer Shue

Jennifer Shue is the Director of Clinical Research and her work supports the Spine Care Institute’s mission to advancing the quality of life in spine patients. Jennifer earned her B.S. in biology from the University of California, Los Angeles and M.S. in Clinical Research Organization and Management from the Drexel University College of Medicine. She is a certified research professional through the Association of Clinical Research Professionals.

She has amassed 12 years of clinical research experience in pharmaceutical, biologics, and medical device fields. Her therapeutic areas of expertise include cardiology, endocrinology, genetics, hematology, and orthopedics. She successfully advanced numerous research projects from concept through publication. Her research portfolio includes oversight of IND Phase I-III clinical trials, PMS or Phase IV studies, IDE clinical trials, PMA studies, and investigator-initiated research. Jennifer has worked with physicians and scientists responsible for developing novel therapies and enhancing patient care in spinal surgery. She continues to provide strategic and research leadership to investigative teams and joint collaborators.

Jennifer Shue